10 | Calcitonin Gene-Related PeptideIBA
12/2021
-
01/2017 |
8 | Nitroglycerin (Dynamite)FDA LinkGeneric
02/2022
-
12/2012 |
8 | Analgesics (Analgesic Drugs)IBA
01/2018
-
10/2011 |
3 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017
-
12/2012 |
2 | Purinergic Receptors (Receptors, Purine)IBA
01/2021
-
11/2019 |
2 | Metabotropic Glutamate 5 ReceptorIBA
01/2021
-
12/2020 |
2 | Proteins (Proteins, Gene)FDA Link
11/2020
-
04/2019 |
2 | Glutamic Acid (Glutamate)FDA Link
11/2020
-
11/2020 |
2 | Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020
-
01/2018 |
2 | Protein Kinase CIBA
01/2019
-
10/2017 |
2 | Purinergic P2X4 ReceptorsIBA
08/2018
-
01/2018 |
2 | tetrandrineIBA
01/2018
-
07/2013 |
2 | Tyrosine (L-Tyrosine)FDA Link
01/2017
-
04/2016 |
2 | Capsules (Microcapsules)IBA
09/2016
-
01/2015 |
2 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2016
-
12/2012 |
2 | TensinsIBA
04/2016
-
12/2012 |
2 | 4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
09/2013
-
06/2012 |
1 | lasmiditanIBA
09/2022 |
1 | olcegepantIBA
03/2022 |
1 | Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
03/2022 |
1 | Phosphates (Orthophosphate)IBA
02/2022 |
1 | Sphingosine-1-Phosphate ReceptorsIBA
02/2022 |
1 | Sirtuin 1IBA
12/2021 |
1 | AntagomirsIBA
12/2021 |
1 | Peroxidase (Myeloperoxidase)IBA
12/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
12/2021 |
1 | SRT1720IBA
12/2021 |
1 | Oxytocin Receptors (Oxytocin Receptor)IBA
07/2021 |
1 | Oxytocin (Pitocin)FDA LinkGeneric
07/2021 |
1 | Sirolimus (Rapamycin)FDA Link
01/2021 |
1 | Purinergic P2X7 ReceptorsIBA
01/2021 |
1 | coomassie Brilliant BlueIBA
01/2021 |
1 | Glutamate Receptors (Glutamate Receptor)IBA
01/2021 |
1 | Substance PIBA
01/2021 |
1 | Serine (L-Serine)FDA Link
12/2020 |
1 | Adenosine Monophosphate (AMP)IBA
12/2020 |
1 | Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
12/2020 |
1 | Vesicular Glutamate Transport Protein 2IBA
11/2020 |
1 | BaclofenFDA LinkGeneric
11/2020 |
1 | LDN-OSU-0212320IBA
11/2020 |
1 | Excitatory Amino Acid Transporter 2IBA
11/2020 |
1 | N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
11/2020 |
1 | 8-Bromo Cyclic Adenosine Monophosphate (8 Bromo Cyclic Adenosine Monophosphate)IBA
11/2020 |
1 | Messenger RNA (mRNA)IBA
06/2020 |
1 | Protein Kinases (Protein Kinase)IBA
01/2020 |
1 | Clopidogrel (Plavix)FDA Link
11/2019 |
1 | Guanosine Triphosphate (GTP)IBA
11/2019 |
1 | fasudil (AT 877)IBA
11/2019 |
1 | 2,2-dimethylpropionic acid 3- (2- chloro- 6- methylaminopurin- 9- yl)- 2- (2,2- dimethylpropionyloxymethyl)propyl esterIBA
11/2019 |
1 | Adenylyl Cyclases (Adenylyl Cyclase)IBA
07/2019 |
1 | NeuropeptidesIBA
07/2019 |
1 | Peptides (Polypeptides)IBA
07/2019 |
1 | Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2019 |
1 | InflammasomesIBA
04/2019 |
1 | InterleukinsIBA
04/2019 |
1 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
04/2019 |
1 | Oxygen (Dioxygen)IBA
01/2019 |
1 | chelerythrineIBA
01/2019 |
1 | Nerve Growth Factor (NGF)IBA
01/2019 |
1 | Acid Sensing Ion ChannelsIBA
01/2019 |
1 | Neutralizing AntibodiesIBA
01/2019 |
1 | Minocycline (Cyclops)FDA LinkGeneric
08/2018 |
1 | Phosphotransferases (Kinase)IBA
01/2018 |
1 | NicotineFDA Link
01/2018 |
1 | Pharmaceutical PreparationsIBA
01/2018 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2018 |
1 | Sertraline (Zoloft)FDA LinkGeneric
01/2018 |
1 | 6,7-dihydroxyflavoneIBA
01/2018 |
1 | Excitatory Amino Acid Transporter 3IBA
01/2018 |
1 | tyrosine receptor (receptor, tyrosine)IBA
01/2018 |
1 | GenisteinIBA
01/2017 |
1 | N-Methylaspartate (NMDA)IBA
01/2017 |
1 | Tryptamines (Triptans)IBA
12/2016 |
1 | FlunarizineIBA
09/2016 |
1 | Indicators and Reagents (Reagents)IBA
04/2016 |
1 | Fibronectins (Fibronectin)IBA
05/2015 |
1 | Laminin (Merosin)IBA
05/2015 |
1 | Amitriptyline (Elavil)FDA LinkGeneric
10/2014 |
1 | DNA (Deoxyribonucleic Acid)IBA
04/2014 |